Immunogen (IMGN) CEO Buys 25K Shares

November 9, 2016 1:37 PM EST

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Immunogen (NASDAQ: IMGN) CEO, Mark Enyedy, bought 25,000 shares on 11/08 at $1.83.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Insider Trades

Add Your Comment